Clinical Scorecard: Reevaluating Immunosuppression Following Stroke: Moving Beyond Traditional Perspectives
At a Glance
Category
Detail
Condition
Key Mechanisms
Biphasic immune response: early inflammatory reaction followed by peripheral immunosuppression, including activation of the autonomic nervous system, DAMPs release, and changes in lymphocyte dynamics.
Target Population
Care Setting
Key Highlights
Ischemic stroke leads to systemic complications, including stroke-induced immunosuppression (SIIS).
SIIS is associated with increased susceptibility to infections, particularly pneumonia.
Mechanisms include activation of the autonomic nervous system, DAMPs release, and changes in lymphocyte dynamics.
Lymphopenia, particularly of CD4+ T cells, is a significant feature of SIIS.
Understanding SIIS is crucial for improving post-stroke outcomes.
The interaction within a neuroimmune network may influence the development of SIIS.
Guideline-Based Recommendations
Diagnosis
Monitor for signs of immunosuppression post-stroke, including lymphopenia and DAMPs.
Management
Consider strategies to mitigate the risk of infections in stroke patients.
Monitoring & Follow-up
Regularly assess immune function and infection rates in stroke survivors, including specific immune markers.
Risks
Increased risk of post-stroke infections and poorer clinical outcomes.
Patient & Prescribing Data
Patients recovering from ischemic stroke.
Focus on managing systemic immune alterations to improve recovery.
Clinical Best Practices
Implement early screening for infections in stroke patients.
Educate healthcare providers on the implications of SIIS.
Develop protocols for monitoring immune function in stroke rehabilitation, focusing on the transition from neuroinflammation to immunosuppression.
